Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.50d agobearish
Did VOXZOGO’s Hypochondroplasia Win and New R&D Hire Just Reframe BioMarin’s (BMRN) Investment Narrative?Investor's Business Daily72d agobearish
Cytokinetics Scores A First-Ever In Its Rivalry Against Bristol MyersSimply Wall St.85d agobearish
What Does Bristol Myers Squibb (BMY) Risk From The Revived $6.7 Billion Lawsuit?InvestorsHub95d agobearish
AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculationBarrons.com97d agobearish
Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZenecaThe Wall Street Journal97d agobearish
U.S. Stock Futures Rise, Oil Falls as U.S. Shifts Toward Diplomacy with IranThe Wall Street Journal97d agobearish
AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger TalksBioPharma Dive102d agobearish
MapLight CEO on what investors missed in the biotech’s schizophrenia dataProactive103d agobearish
Replimune shares fall after FDA reviewers raise doubts over RP1 melanoma drug efficacyMarketBeat104d agobearish
Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing NowSimply Wall St.122d agobearish
Is Janux Therapeutics’ (JANX) Russell Index Exit Quietly Rewriting Its Investor Base and Story?Simply Wall St.131d agobearish
Bristol Myers Squibb (BMY) Moves From Russell Growth Indexes To Value And Defensive